A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease

Kheirkhah Ahmad; Di Zazzo Antonio; Satitpitakul Vannarut; Fernandez Merle; Magilavy Daniel; Dana Reza

首页> 外文期刊>Investigative ophthalmology & visual science >A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease

【24h】

A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease

机译：Janus激酶1/3和脾酪氨酸激酶对GVHD相关的眼部疾病的新型局部组合抑制剂的安全性和疗效的随机试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共2页
作者
Kheirkhah Ahmad; Di Zazzo Antonio; Satitpitakul Vannarut; Fernandez Merle; Magilavy Daniel; Dana Reza;
展开▼
作者单位

Massachusetts Eye &

Ear Infirm Ophthalmol Boston MA 02114 USA;

Massachusetts Eye &

Ear Infirm Ophthalmol Boston MA 02114 USA;

Massachusetts Eye &

Ear Infirm Ophthalmol Boston MA 02114 USA;

Massachusetts Eye &

Ear Infirm Ophthalmol Boston MA 02114 USA;

Rigel Pharmaceut Inc San Francisco CA USA;

Massachusetts Eye &

Ear Infirm Ophthalmol Boston MA 02114 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. A Pilot Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-Associated Ocular Surface Disease [J] . Kheirkhah Ahmad, Di Zazzo Antonio, Satitpitakul Vannarut, Cornea . 2017,第7期

机译：试点随机试验关于Janus激酶1/3和脾脏酪氨酸激酶的新型局部组合抑制剂的安全性和功效，用于GVHD相关的眼表面疾病
2. A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease [J] . Kheirkhah Ahmad, Di Zazzo Antonio, Satitpitakul Vannarut, Investigative ophthalmology & visual science . 2017,第8期

机译：Janus激酶1/3和脾酪氨酸激酶对GVHD相关的眼部疾病的新型局部组合抑制剂的安全性和疗效的随机试验
3. A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease [J] . Kheirkhah Ahmad, Di Zazzo Antonio, Satitpitakul Vannarut, Investigative ophthalmology & visual science . 2017,第8期

机译：Janus激酶1/3和脾酪氨酸激酶对GVHD相关的眼部疾病的新型局部组合抑制剂的安全性和疗效的随机试验
4. Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma [C] . Yeul Hong Kim, Hye Sook Kim, Jae Sook Sung, Molecular Medicine TRI-CON. . 2014

机译：下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis [O] . WC Ports, S Khan, S Lan, -1

机译：局部Janus激酶抑制剂托法替尼治疗慢性斑块状牛皮癣的随机2a期疗效和安全性试验
7. Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study [O] . H. Nakagawa, O. Nemoto, A. Igarashi, 2018

机译：局部JTE-052，Janus激酶抑制剂的疗效和安全性，日本成年患者中度至严重的特征性皮炎：II期，多期，随机，车辆控制的临床研究

A Randomized Trial on Safety and Efficacy of a Novel Topical Combined Inhibitor of Janus Kinase 1/3 and Spleen Tyrosine Kinase for GVHD-associated Ocular Surface Disease

著录项

相似文献

相关主题

期刊订阅